Molecular nature of radiation injury and DNA repair disorders associated with radiosensitivity

International Journal of Hematology

Volumn 95, Issue 3, 2012, Pages 239-245

  Masuda, Yuji ^a,b   Kamiya, Kenji ^b  

^a NAGOYA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Ataxia telangiectasia; Double stranded DNA breaks; Ionizing radiation; Non homologous end joining; Severe combined immunodeficiency

Indexed keywords

DOUBLE STRANDED DNA;

ARTICLE; CHEMICAL STRUCTURE; CLINICAL FEATURE; CYTOLOGY; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DOUBLE STRANDED DNA BREAK; HUMAN; IMMUNE SYSTEM; LEUKEMIA; LYMPHOMA; NONHUMAN; RADIATION INJURY; RADIOSENSITIVITY;

ANIMALS; DNA BREAKS; DNA REPAIR-DEFICIENCY DISORDERS; HUMANS; LEUKEMIA; LYMPHOMA; MICE; NEOPLASMS, RADIATION-INDUCED; RADIATION INJURIES; RADIATION TOLERANCE; RISK;

EID: 84862991920     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1008-y     Document Type: Article

References (80)

1. Gotoff SP, Amirmokri E, Liebner EJ. Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis. Am J Dis Child. 1967;114:617-25.
2. Shapiro R. Damage to DNA caused by hydrolysis. In: Seeberg E, Kleppe K, editors. Chromosome damage and repair. New York: Plenum Publishing Corp.; 1981.
3. Greer S, Zamenhof S. Studies on depurination of DNA by heat. J Mol Biol. 1962;4:123-41.
4. Breen AP, Murphy JA. Reactions of oxyl radicals with DNA. Free Radic Biol Med. 1995;18:1033-77.
5. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res. 1992;275:331-42.
6. Lindahl T. Instability and decay of the primary structure of DNA. Nature. 1993;362:709-15. (Pubitemid 23125973)
7. Singer B, Kusmierek JT. Chemical mutagenesis. Annu Rev Biochem. 1982;51:655-93. (Pubitemid 12024692)
8. Cosman M, de los Santos C, Fiala R, Hingerty BE, Singh SB, Ibanez V, Margulis LA, Live D, Geacintov NE, Broyde S, et al. Solution conformation of the major adduct between the carcinogen (?)-anti-benzo[a]pyrene diol epoxide and DNA. Proc Natl Acad Sci USA. 1992;89:1914-8.
9. Vilenchik MM, Knudson AG Jr. Inverse radiation dose-rate effects on somatic and germ-line mutations and DNA damage rates. Proc Natl Acad Sci USA. 2000;97:5381-6. (Pubitemid 30313727)
10. Ward JF. DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog Nucleic Acid Res Mol Biol. 1988;35:95-125.
11. Caldecott KW. Single-strand break repair and genetic disease. Nat Rev Genet. 2008;9:619-31.
12. Morgan JL, Holcomb TM, Morrissey RW. Radiation reaction in ataxia telangiectasia. Am J Dis Child. 1968;116:557-8.
13. Taylor AM, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 1975;258:427-9.
14. Taalman RD, Jaspers NG, Scheres JM, de Wit J, Hustinx TW. Hypersensitivity to ionizing radiation, in vitro, in a new chromosomal breakage disorder, the Nijmegen breakage syndrome. Mutat Res. 1983;112:23-32. (Pubitemid 13180528)
15. Fiorilli M, Antonelli A, Russo G, Crescenzi M, Carbonari M, Petrinelli P. Variant of ataxia-telangiectasia with low-level radiosensitivity. Hum Genet. 1985;70:274-7. (Pubitemid 15234385)
16. Barbi G, Scheres JM, Schindler D, Taalman RD, Rodens K, Mehnert K, Muller M, Seyschab H. Chromosome instability and X-ray hypersensitivity in a microcephalic and growth-retarded child. Am J Med Genet. 1991;40:44-50.
17. Hernandez D, McConville CM, Stacey M, Woods CG, Brown MM, Shutt P, Rysiecki G, Taylor AM. A family showing no evidence of linkage between the ataxia telangiectasia gene and chromosome 11q22-23. J Med Genet. 1993;30:135-40. (Pubitemid 23078391)
18. Waltes R, Kalb R, Gatei M, Kijas AW, Stumm M, Sobeck A, Wieland B, Varon R, Lerenthal Y, Lavin MF, Schindler D, Dork T. Human RAD50 deficiency in a Nijmegen breakage syndromelike disorder. Am J Hum Genet. 2009;84:605-16.
19. Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, Yates JR 3rd, Hays L, Morgan WF, Petrini JH. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell. 1998;93:477-86. (Pubitemid 28232091)
20. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268:1749-53.
21. Matsuura S, Tauchi H, Nakamura A, Kondo N, Sakamoto S, Endo S, Smeets D, Solder B, Belohradsky BH, Der Kaloustian VM, Oshimura M, Isomura M, Nakamura Y, Komatsu K. Positional cloning of the gene for Nijmegen breakage syndrome. Nat Genet. 1998;19:179-81. (Pubitemid 28248802)
22. Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NG, Raams A, Byrd PJ, Petrini JH, Taylor AM. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell. 1999;99: 577-87. (Pubitemid 30004634)
23. van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, Morotomi-Yano K, Mari PO, Tezcan I, Chen DJ, Zdzienicka MZ, van Dongen JJ, van Gent DC. A DNA-PKcs mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining. J Clin Invest. 2009;119:91-8.
24. Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana- Calvo M, Le Deist F, Tezcan I, Sanal O, Bertrand Y, Philippe N, Fischer A, de Villartay JP. Artemis, a novel DNA doublestrand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 2001;105:177-86. (Pubitemid 32429508)
25. Li L, Moshous D, Zhou Y, Wang J, Xie G, Salido E, Hu D, de Villartay JP, Cowan MJ. A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans. J Immunol. 2002;168:6323-9. (Pubitemid 34620054)
26. Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, Kysela B, Beamish H, Plowman N, Arlett CF, Lehmann AR, Jackson SP, Jeggo PA. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol. 1999;9:699-702. (Pubitemid 29332352)
27. Lavin MF, Schroeder AL. Damage-resistant DNA synthesis in eukaryotes. Mutat Res. 1988;193:193-206.
28. Jaspers NG, Zdzienicka MZ. Inhibition of DNA synthesis by ionizing radiation: a marker for an S-phase checkpoint. Methods Mol Biol. 2006;314:51-9.
29. Taalman RD, Hustinx TW, Weemaes CM, Seemanova E, Schmidt A, Passarge E, Scheres JM. Further delineation of the Nijmegen breakage syndrome. Am J Med Genet. 1989;32:425-31. (Pubitemid 19146552)
30. Jaspers NG, Gatti RA, Baan C, Linssen PC, Bootsma D. Genetic complementation analysis of ataxia telangiectasia and Nijmegen breakage syndrome: a survey of 50 patients. Cytogenet Cell Genet. 1988;49:259-63. (Pubitemid 19154985)
31. Chrzanowska KH, Kleijer WJ, Krajewska-Walasek M, Bialecka M, Gutkowska A, Goryluk-Kozakiewicz B, Michalkiewicz J, Stachowski J, Gregorek H, Lyson-Wojciechowska G, et al. Eleven Polish patients with microcephaly, immunodeficiency, and chromosomal instability: the Nijmegen breakage syndrome. Am J Med Genet. 1995;57:462-71.
32. Kraakman-van der Zwet M, Overkamp WJ, Friedl AA, Klein B, Verhaegh GW, Jaspers NG, Midro AT, Eckardt-Schupp F, Lohman PH, Zdzienicka MZ. Immortalization and characterization of Nijmegen breakage syndrome fibroblasts. Mutat Res. 1999;434:17-27. (Pubitemid 29240694)
33. Jeggo PA, Carr AM, Lehmann AR. Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia. Trends Genet. 1998;14:312-6. (Pubitemid 28378268)
34. O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J, Gatti RA, Varon R, Oettinger MA, Neitzel H, Jeggo PA, Concannon P. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell. 2001; 8:1175-85. (Pubitemid 34084990)
35. Falck J, Coates J, Jackson SP. Conserved modes of recruitment of ATM ATR and DNA-PKcs to sites of DNA damage. Nature. 2005;434:605-11. (Pubitemid 40488547)
36. Williams RS, Williams JS, Tainer JA. Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, doublestrand break signaling, and the chromatin template. Biochem Cell Biol. 2007;85:509-20. (Pubitemid 47518045)
37. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007;316:1160-6. (Pubitemid 46877472)
38. Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature. 2003;421:961-6. (Pubitemid 36288029)
39. Lou Z, Minter-Dykhouse K, Wu X, Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature. 2003;421:957-61. (Pubitemid 36288028)
40. Costanzo V, Robertson K, Bibikova M, Kim E, Grieco D, Gottesman M, Carroll D, Gautier J. Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. Mol Cell. 2001;8:137-47. (Pubitemid 32772912)
41. Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem. 2001;276:42462-7.
42. Goldberg M, Stucki M, Falck J, D'Amours D, Rahman D, Pappin D, Bartek J, Jackson SP. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature. 2003;421:952-6. (Pubitemid 36288027)
43. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 1998;281:1677-9. (Pubitemid 28435584)
44. Kang J, Ferguson D, Song H, Bassing C, Eckersdorff M, Alt FW, Xu Y. Functional interaction of H2AX, NBS1, and p53 in ATMdependent DNA damage responses and tumor suppression. Mol Cell Biol. 2005;25:661-70. (Pubitemid 40096587)
45. Hartley KO, Gell D, Smith GC, Zhang H, Divecha N, Connelly MA, Admon A, Lees-Miller SP, Anderson CW, Jackson SP. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell. 1995;82:849-56.
46. Dobbs TA, Tainer JA, Lees-Miller SP. A structural model for regulation of NHEJ by DNA-PKcs autophosphorylation. DNA Repair (Amst). 2010;9:1307-14.
47. Pannicke U, Ma Y, Hopfner KP, Niewolik D, Lieber MR, Schwarz K. Functional and biochemical dissection of the structure- specific nuclease ARTEMIS. EMBO J. 2004;23:1987-97. (Pubitemid 38902077)
48. Ma Y, Schwarz K, Lieber MR. The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps. DNA Repair (Amst). 2005;4:845-51. (Pubitemid 40835856)
49. Grawunder U, Wilm M, Wu X, Kulesza P, Wilson TE, Mann M, Lieber MR. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature. 1997; 388:492-5. (Pubitemid 27328929)
50. Critchlow SE, Bowater RP, Jackson SP. Mammalian DNA double- strand break repair protein XRCC4 interacts with DNA ligase IV. Curr Biol. 1997;7:588-98. (Pubitemid 27335654)
51. Strober W, Wochner RD, Barlow MH, McFarlin DE, Waldmann TA. Immunoglobulin metabolism in ataxia telangiectasia. J Clin Invest. 1968;47:1905-15.
52. McFarlin DE, Strober W, Waldmann TA. Ataxia-telangiectasia. Medicine (Baltimore). 1972;51:281-314.
53. Gatti RA, Bick M, Tam CF, Medici MA, Oxelius VA, Holland M, Goldstein AL, Boder E. Ataxia-Telangiectasia: a multiparameter analysis of eight families. Clin Immunol Immunopathol. 1982;23:501-16. (Pubitemid 12093019)
54. Oxelius VA, Berkel AI, Hanson LA. IgG2 deficiency in ataxiatelangiectasia. N Engl J Med. 1982;306:515-7.
55. Weemaes CM, Smeets DF, van der Burgt CJ. Nijmegen breakage syndrome: a progress report. Int J Radiat Biol. 1994;66:S185-8.
56. van Engelen BG, Hiel JA, Gabreels FJ, van den Heuvel LP, van Gent DC, Weemaes CM. Decreased immunoglobulin class switching in Nijmegen breakage syndrome due to the DNA repair defect. Hum Immunol. 2001;62:1324-7. (Pubitemid 33116969)
57. Gregorek H, Chrzanowska KH, Michalkiewicz J, Syczewska M, Madalinski K. Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year followup study in a single centre. Clin Exp Immunol. 2002;130:319-24. (Pubitemid 35286221)
58. Pan Q, Petit-Frere C, Lahdesmaki A, Gregorek H, Chrzanowska KH, Hammarstrom L. Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur J Immunol. 2002;32:1300-8. (Pubitemid 34546257)
59. Pan-Hammarstrom Q, Dai S, Zhao Y, van Dijk-Hard IF, Gatti RA, Borresen-Dale AL, Hammarstrom L. ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region. J Immunol. 2003;170: 3707-16. (Pubitemid 36359241)
60. Reina-San-Martin B, Chen HT, Nussenzweig A, Nussenzweig MC. ATM is required for efficient recombination between immunoglobulin switch regions. J Exp Med. 2004;200:1103-10. (Pubitemid 39507050)
61. Lumsden JM, McCarty T, Petiniot LK, Shen R, Barlow C, Wynn TA, Morse HC 3rd, Gearhart PJ, Wynshaw-Boris A, Max EE, Hodes RJ. Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J Exp Med. 2004;200:1111-21. (Pubitemid 39507051)
62. Kracker S, Bergmann Y, Demuth I, Frappart PO, Hildebrand G, Christine R, Wang ZQ, Sperling K, Digweed M, Radbruch A. Nibrin functions in Ig class-switch recombination. Proc Natl Acad Sci USA. 2005;102:1584-9. (Pubitemid 40209211)
63. Reina-San-Martin B, Nussenzweig MC, Nussenzweig A, Difilippantonio S. Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc Natl Acad Sci USA. 2005;102:1590-5. (Pubitemid 40209212)
64. Jones JF, Ritenbaugh CK, Spence MA, Hayward A. Severe combined immunodeficiency among the Navajo. I. Characterization of phenotypes, epidemiology, and population genetics. Hum Biol. 1991;63:669-82.
65. van der Burg M, van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH, Brugmans L, Raams A, Jaspers NG, Zdzienicka MZ, van Dongen JJ, van Gent DC. A new type of radiosensitive T-B-NK? severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest. 2006;116:137-45. (Pubitemid 43121798)
66. Blunt T, Finnie NJ, Taccioli GE, Smith GC, Demengeot J, Gottlieb TM, Mizuta R, Varghese AJ, Alt FW, Jeggo PA, et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine SCID mutation. Cell. 1995;80:813-23.
67. Shin EK, Perryman LE, Meek K. A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation. J Immunol. 1997;158:3565-9. (Pubitemid 127488707)
68. Meek K, Kienker L, Dallas C, Wang W, Dark MJ, Venta PJ, Huie ML, Hirschhorn R, Bell T. SCID in Jack Russell terriers: a new animal model of DNA-PKcs deficiency. J Immunol. 2001;167: 2142-50. (Pubitemid 32747523)
69. Rooney S, Sekiguchi J, Zhu C, Cheng HL, Manis J, Whitlow S, DeVido J, Foy D, Chaudhuri J, Lombard D, Alt FW. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell. 2002;10:1379-90. (Pubitemid 36050879)
70. Nijnik A, Dawson S, Crockford TL, Woodbine L, Visetnoi S, Bennett S, Jones M, Turner GD, Jeggo PA, Goodnow CC, Cornall RJ. Impaired lymphocyte development and antibody class switching and increased malignancy in a murine model of DNA ligase IV syndrome. J Clin Invest. 2009;119:1696-705.
71. Taylor AM, Metcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87:423-38. (Pubitemid 26030297)
72. Liao MJ, Van Dyke T. Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma. Genes Dev. 1999;13: 1246-50. (Pubitemid 29250192)
73. Seidemann K, Tiemann M, Henze G, Sauerbrey A, Muller S, Reiter A. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials. Med Pediatr Oncol. 1999;33:536-44.
74. van Gorp J, Doornewaard H, Verdonck LF, Klopping C, Vos PF, van den Tweel JG. Posttransplant T-cell lymphoma. Report of three cases and a review of the literature. Cancer. 1994;73: 3064-72. (Pubitemid 24170783)
75. Ben-Omran TI, Cerosaletti K, Concannon P, Weitzman S, Nezarati MM. A patient with mutations in DNA ligase IV: clinical features and overlap with Nijmegen breakage syndrome. Am J Med Genet A. 2005;137A:283-7. (Pubitemid 41262661)
76. Moshous D, Pannetier C, Chasseval Rd R, Deist Fl F, Cavazzana- Calvo M, Romana S, Macintyre E, Canioni D, Brousse N, Fischer A, Casanova JL, Villartay JP. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest. 2003; 111:381-7. (Pubitemid 36182215)
77. Enders A, Fisch P, Schwarz K, Duffner U, Pannicke U, Nikolopoulos E, Peters A, Orlowska-Volk M, Schindler D, Friedrich W, Selle B, Niemeyer C, Ehl S. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol. 2006;176:5060-8.
78. Toita N, Hatano N, Ono S, Yamada M, Kobayashi R, Kobayashi I, Kawamura N, Okano M, Satoh A, Nakagawa A, Ohshima K, Shindoh M, Takami T, Kobayashi K, Ariga T. Epstein-Barr virusassociated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am J Med Genet A. 2007;143:742-5. (Pubitemid 46606685)
79. Vanasse GJ, Halbrook J, Thomas S, Burgess A, Hoekstra MF, Disteche CM, Willerford DM. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. J Clin Invest. 1999;103:1669-75. (Pubitemid 29534361)
80. Williams CJ, Grandal I, Vesprini DJ, Wojtyra U, Danska JS, Guidos CJ. Irradiation promotes V(D)J joining and RAGdependent neoplastic transformation in SCID T-cell precursors. Mol Cell Biol. 2001;21:400-13. (Pubitemid 32037361)